Law360, New York (April 08, 2008) -- Pharmaceutical giant Johnson & Johnson and plaintiffs in multidistrict litigation alleging J&J's popular birth control patch Ortho-Evra may increase users' risk of developing dangerous blood clots sparred over expert testimony on Monday, with each seeking to disqualify the other's witnesses.
In a preliminary motion filed in the U.S. District Court for the Northern District of Ohio, the plaintiffs asked the court to strike all or part of the opinions of...
